Logic Regression Analysis of Gene Polymorphisms and HDL Levels in a Nationally Representative Sample of Iranian Adolescents: The CASPIAN-III Study

Authors Information
Article Notes and Dates
To Cite : Moghadasi M, Kelishadi R, Marateb H R, Haghjooy Javanmard S, Mansourian M, et al. Logic Regression Analysis of Gene Polymorphisms and HDL Levels in a Nationally Representative Sample of Iranian Adolescents: The CASPIAN-III Study, Int J Endocrinol Metab. 2017 ;15(3):e14037. doi: 10.5812/ijem.14037.
Copyright: Copyright © 2017, International Journal of Endocrinology and Metabolism. .
Abstract
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11)[DOI][PubMed]
  • 2. Frontini MG, Srinivasan SR, Xu J, Tang R, Bond MG, Berenson GS. Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study. Pediatrics. 2008; 121(5): 924-9[DOI][PubMed]
  • 3. Lauer RM, Clarke WR. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia. The Muscatine Study. JAMA. 1990; 264(23): 3034-8[DOI][PubMed]
  • 4. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32(6): 1092-7[DOI][PubMed]
  • 5. Ribas SA, Santana da Silva LC. Anthropometric indices: predictors of dyslipidemia in children and adolescents from north of Brazil. Nutr Hosp. 2012; 27(4): 1228-35[DOI][PubMed]
  • 6. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007; 357(21): 2109-22[DOI][PubMed]
  • 7. Gotto AJ, Brinton EA. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Coll Cardiol. 2004; 43(5): 717-24[DOI][PubMed]
  • 8. Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W, Hasani MR, Yusufali AH, et al. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. Eur J Prev Cardiol. 2014; 21(4): 400-10[DOI][PubMed]
  • 9. Kelishadi R, Gheiratmand R, Ardalan G, Adeli K, Mehdi Gouya M, Mohammad Razaghi E, et al. Association of anthropometric indices with cardiovascular disease risk factors among children and adolescents: CASPIAN Study. Int J Cardiol. 2007; 117(3): 340-8[DOI][PubMed]
  • 10. Kelishadi R, Motlagh ME, Roomizadeh P, Abtahi SH, Qorbani M, Taslimi M, et al. First report on path analysis for cardiometabolic components in a nationally representative sample of pediatric population in the Middle East and North Africa (MENA): the CASPIAN-III Study. Ann Nutr Metab. 2013; 62(3): 257-65[DOI][PubMed]
  • 11. Kelishadi R, Ardalan G, Gheiratmand R, Ramezani A. Is family history of premature cardiovascular diseases appropriate for detection of dyslipidemic children in population-based preventive medicine programs? CASPIAN study. Pediatr Cardiol. 2006; 27(6): 729-36[DOI][PubMed]
  • 12. Schwandt P, Kelishadi R, Haas GM. Ethnic disparities of the metabolic syndrome in population-based samples of german and Iranian adolescents. Metab Syndr Relat Disord. 2010; 8(2): 189-92[DOI][PubMed]
  • 13. Qasim A, Rader DJ. Human genetics of variation in high-density lipoprotein cholesterol. Curr Atheroscler Rep. 2006; 8(3): 198-205[DOI][PubMed]
  • 14. Ahmadzadeh A, Azizi F. Genes associated with low serum high-density lipoprotein cholesterol. Arch Iran Med. 2014; 17(6): 444-50[PubMed]
  • 15. Snieder H, van Doornen LJ, Boomsma DI. Dissecting the genetic architecture of lipids, lipoproteins, and apolipoproteins: lessons from twin studies. Arterioscler Thromb Vasc Biol. 1999; 19(12): 2826-34[DOI][PubMed]
  • 16. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001; 409(6822): 860-921[DOI][PubMed]
  • 17. Culverhouse R, Suarez BK, Lin J, Reich T. A perspective on epistasis: limits of models displaying no main effect. Am J Hum Genet. 2002; 70(2): 461-71[DOI][PubMed]
  • 18. Kelishadi R, Haghjooy Javanmard S, Tajadini MH, Mansourian M, Motlagh ME, Ardalan G, et al. Genetic association with low concentrations of high density lipoprotein-cholesterol in a pediatric population of the Middle East and North Africa: the CASPIAN-III study. Atherosclerosis. 2014; 237(1): 273-8[DOI][PubMed]
  • 19. Kelishadi R, Heshmat R, Motlagh ME, Majdzadeh R, Keramatian K, Qorbani M, et al. Methodology and Early Findings of the Third Survey of CASPIAN Study: A National School-based Surveillance of Students' High Risk Behaviors. Int J Prev Med. 2012; 3(6): 394-401[PubMed]
  • 20. Kwiterovich PJ. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab. 2008; 93(11): 4200-9[DOI][PubMed]
  • 21. Gupta N, Goel K, Shah P, Misra A. Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocr Rev. 2012; 33(1): 48-70[DOI][PubMed]
  • 22. Brunham LR, Hayden MR. Human genetics of HDL: Insight into particle metabolism and function. Prog Lipid Res. 2015; 58: 14-25[DOI][PubMed]
  • 23. Ruczinski I, Kooperberg C, LeBlanc M. Logic Regression. J Comput Graph Stat. 2003; 12(3): 475-511[DOI]
  • 24. Askari G, Heidari-Beni M, Mansourian M, Esmaeil-Motlagh M, Kelishadi R. Interaction of lipoprotein lipase polymorphisms with body mass index and birth weight to modulate lipid profiles in children and adolescents: the CASPIAN-III Study. Sao Paulo Med J. 2016; 134(2): 121-9[DOI][PubMed]
  • 25. Schwender H, Ruczinski I. Logic regression and its extensions. Adv Genet. 2010; 72: 25-45[DOI][PubMed]
  • 26. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002; (246): 1-190[PubMed]
  • 27. El-Lebedy D, Raslan HM, Mohammed AM. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2016; 15: 12[DOI][PubMed]
  • 28. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K, et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003; 107(11): 1562-6[DOI][PubMed]
  • 29. Daniels SR, Greer FR, Committee on N. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008; 122(1): 198-208[DOI][PubMed]
  • 30. Boekholdt SM, Thompson JF. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res. 2003; 44(6): 1080-93[DOI][PubMed]
  • 31. Lu Y, Tayebi N, Li H, Saha N, Yang H, Heng CK. Association of CETP Taq1B and -629C > A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population. Lipids Health Dis. 2013; 12: 85[DOI][PubMed]
  • 32. Ruan X, Ma L, Wang S, Lindpaintner K, Liu X, Wang B, et al. Association of two CETP polymorphisms with HDL levels in the Chinese obese population. Obesity (Silver Spring). 2009; 17(12): 2196-201[DOI][PubMed]
  • 33. Heidari-Beni M, Kelishadi R, Mansourian M, Askari G. Interaction of cholesterol ester transfer protein polymorphisms, body mass index, and birth weight with the risk of dyslipidemia in children and adolescents: the CASPIAN-III study. Iran J Basic Med Sci. 2015; 18(11): 1079-85[PubMed]
  • 34. Rahimi Z, Nourozi-Rad R, Vaisi-Raygani A, Saidi MR, Rahimi Z, Ahmadi R, et al. Association between cholesteryl ester transfer protein TaqIB variants and risk of coronary artery disease and diabetes mellitus in the population of western Iran. Genet Test Mol Biomarkers. 2011; 15(11): 813-9[DOI][PubMed]
  • 35. Smart MC, Dedoussis G, Louizou E, Yannakoulia M, Drenos F, Papoutsakis C, et al. APOE, CETP and LPL genes show strong association with lipid levels in Greek children. Nutr Metab Cardiovasc Dis. 2010; 20(1): 26-33[DOI][PubMed]
  • 36. Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation. 2005; 111(3): 278-87[DOI][PubMed]
  • 37. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol. 2000; 20(5): 1323-9[DOI][PubMed]
  • 38. Wu Y, Bai H, Liu R, Liu Y, Liu BW. [Analysis of cholesterol ester transfer protein gene Taq IB and -629 C/A polymorphisms in patients with endogenous hypertriglyceridemia in Chinese population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006; 23(6): 640-6[PubMed]
  • 39. Kashani Farid MA, Azizi F, Hedayati M, Daneshpour MS, Shamshiri AR, Siassi F. Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study. Lipids Health Dis. 2010; 9: 96[DOI][PubMed]
  • 40. Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Rejeb NB, Nabli N, et al. Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population. J Cardiovasc Med (Hagerstown). 2012; 13(9): 546-53[DOI][PubMed]
  • 41. Dergunov AD. Prediction of the influences of missense mutations on cholesteryl ester transfer protein structure. Arch Biochem Biophys. 2014; 564: 67-73[DOI][PubMed]
  • 42. Tsai MY, Li N, Sharrett AR, Shea S, Jacobs DJ, Tracy R, et al. Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis. Clin Chem. 2009; 55(3): 481-8[DOI][PubMed]
  • 43. Agerholm-Larsen B, Tybjaerg-Hansen A, Schnohr P, Steffensen R, Nordestgaard BG. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study. Circulation. 2000; 102(18): 2197-203[DOI][PubMed]
  • 44. Tsai MY, Johnson C, Kao WH, Sharrett AR, Arends VL, Kronmal R, et al. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2008; 200(2): 359-67[DOI][PubMed]
  • 45. Frikke-Schmidt R. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population. Atherosclerosis. 2010; 208(2): 305-16[DOI][PubMed]
  • 46. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest. 2004; 114(9): 1343-53[DOI][PubMed]
  • 47. Pajukanta P. Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population? J Clin Invest. 2004; 114(9): 1244-7[DOI][PubMed]
  • 48. Guo Z, Wu P, Xie D, Wang Q, Liu Y, Cha Z, et al. A new discovered ABCA1 gene polymorphisms and the association of ABCA1 SNPs with coronary artery disease and plasma lipids in Chinese population. J Med Colleges PLA. 2011; 26(4): 179-90[DOI]
  • 49. Tupitsina T, Slominsky P, Yufereva Y, Perova N, Aronov D, Limborska S. Linkage analysis by a transmission/disequilibrium test of Russian sibling Pairs with coronary artery disease. Balkan J Med Genet. 2007; 10(2): 43-54[DOI]
  • 50. Wang J, Bao YQ, Hu C, Zhang R, Wang CR, Lu JX, et al. Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients. Acta Pharmacol Sin. 2008; 29(2): 252-8[DOI][PubMed]
  • 51. Sagoo GS, Tatt I, Salanti G, Butterworth AS, Sarwar N, van Maarle M, et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol. 2008; 168(11): 1233-46[DOI][PubMed]
  • 52. Munshi A, Babu MS, Kaul S, Rajeshwar K, Balakrishna N, Jyothy A. Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes. J Neurol Sci. 2012; 318(1-2): 51-4[DOI][PubMed]
  • 53. Kolovou GD, Kolovou V, Panagiotakos DB, Vasiliadis I, Giannakopoulou V, Kostakou PM, et al. Study of common variants of the apolipoprotein E and lipoprotein lipase genes in patients with coronary heart disease and variable body mass index. Hormones (Athens). 2015; 14(3): 376-82[DOI][PubMed]
  • 54. Corsetti JP, Gansevoort RT, Navis G, Sparks CE, Dullaart RP. LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP. Atherosclerosis. 2011; 214(2): 373-6[DOI][PubMed]
  • 55. Ceja-Espiritu G, Delgado-Enciso I, Ramirez-Flores M, Guzman-Esquivel J, Baltazar-Rodriguez LM. The D9N, N291S, and T495G Polymorphisms of the Lipoprotein Lipase Gene Are Not Associated with Cerebral Infarction. J Stroke Cerebrovasc Dis. 2016; 25(4): 985-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check